Hepatology, 1527-3350

Journal

More filtering options
  1. Inflammatory and Metabolic Biomarkers and Risk of Liver and Biliary Tract Cancer

    Aleksandrova, K., Boeing, H., Noethlings, U., Jenab, M., Fedirko, V., Kaaks, R., Lukanova, A., Trichopoulou, A., Trichopoulos, D., Boffetta, P., Trepo, E., Westhpal, S., Duarte-Salles, T., Stepien, M., Overvad, K., Tjonneland, A., Halkjaer, J., Boutron-Ruault, M-C., Dossus, L., Racine, A. & 28 others, Lagiou, P., Bamia, C., Benetou, V., Agnoli, C., Palli, D., Panico, S., Tumino, R., Vineis, P., Bueno-De-Mesquita, B., Peeters, P. H., Gram, I. T., Lund, E., Weiderpass, E., Quiros, J. R., Agudo, A., Sanchez, M-J., Gavrila, D., Barricarte, A., Dorronsoro, M., Bodil Ohlsson, Lindkvist, B., Johansson, A., Sund, M., Khaw, K-T., Wareham, N., Travis, R. C., Riboli, E. & Pischon, T., 2014, In : Hepatology. 60, 3, p. 858-871

    Research output: Contribution to journalArticle

  2. Low-To-Moderate Alcohol Consumption has no Impact on Antiviral Response to Combination Therapy In Hcv Patients with Genotype 2 or 3

    Carvalho-Filho, R. J., Verbaan, H., Bjoro, K., Ring-Larsen, H. & Dalgard, O., 2009, In : Hepatology. 50, 4, p. 819

    Research output: Contribution to journalPublished meeting abstract

  3. Il28B Genetic Variation And Treatment Response In Patients With Hcv Genotype 3 Infection

    Dalgard, O., Moghaddam, A., Verbaan, H., Ring-Larsen, H., Bjoro, K. & Melum, E., 2010, In : Hepatology. 52, 4, p. 898

    Research output: Contribution to journalPublished meeting abstract

  4. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

    Dalgard, O., Bjoro, K., Ring-Larsen, H., Bjornsson, E., Holberg-Petersen, M., Skovlund, E., Reichard, O., Myrvang, B., Sundelof, B., Ritland, S., Hellum, K., Fryden, A., Florholmen, J. & Verbaan, H., 2008, In : Hepatology. 47, 1, p. 35-42

    Research output: Contribution to journalArticle

  5. IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS

    Dalgard, O., Verbaan, H., Ring-Larsen, H. & Bjoro, K., 2008, In : Hepatology. 48, 4, p. 1875

    Research output: Contribution to journalPublished meeting abstract

  6. The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis

    Duffy, D., Mamdouh, R., Laird, M., Soneson, C., Le Fouler, L., El-Daly, M., Casrouge, A., Decalf, J., Abbas, A., Eldin, N. S., Fontes, M., Abdel-Hamid, M., Mohamed, M. K., Rafik, M., Fontanet, A. & Albert, M. L., 2014, In : Hepatology. 59, 4, p. 1273-1282

    Research output: Contribution to journalArticle

  7. Prediagnostic Circulating Vitamin D Levels and Risk of Hepatocellular Carcinoma in European Populations: A Nested Case-Control Study

    Fedirko, V., Duarte-Salles, T., Bamia, C., Trichopoulou, A., Aleksandrova, K., Trichopoulos, D., Trepo, E., Tjonneland, A., Olsen, A., Overvad, K., Boutron-Ruault, M-C., Clavel-Chapelon, F., Kvaskoff, M., Kuehn, T., Lukanova, A., Boeing, H., Buijsse, B., Klinaki, E., Tsimakidi, C., Naccarati, A. & 29 others, Tagliabue, G., Panico, S., Tumino, R., Palli, D., Bueno-de-Mesquita, H. B., Siersema, P. D., Peters, P. H., Lund, E., Brustad, M., Olsen, K. S., Weiderpass, E., Zamora-Ros, R., Sanchez, M-J., Ardanaz, E., Amiano, P., Navarro, C., Ramon Quiros, J., Werner, M., Sund, M., Lindkvist, B., Johan Malm, Travis, R. C., Khaw, K-T., Stepien, M., Scalbert, A., Romieu, I., Lagiou, P., Riboli, E. & Jenab, M., 2014, In : Hepatology. 60, 4, p. 1222-1230

    Research output: Contribution to journalArticle

  8. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of alpha(1)-antitrypsin.

    Sabina Janciauskiene, Eriksson, S., Callea, F., Mallya, M., Zhou, A., Seyarna, K., Hata, S. & Lomas, D. A., 2004, In : Hepatology. 40, 5, p. 1203-1210

    Research output: Contribution to journalArticle

  9. Impact of selective inactivation of transforming growth factor-beta type II receptor gene (TGFBR2) during viral hepatitis

    Lemmer, E. R., Conner, E. A., Leveen, P., Factor, V. M., Tsai, T. L., Huh, C. G., Stefan Karlsson & Thorgeirsson, S. S., 2001, In : Hepatology. 34, 4, Suppl. 2, p. 491A-491A

    Research output: Contribution to journalArticle

Previous 1 2 3 Next